Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CBDC

Apotheca Biosciences (CBDC) Stock Price, News & Analysis

Apotheca Biosciences logo

About Apotheca Biosciences Stock (NASDAQ:CBDC)

Advanced Chart

Key Stats

Today's Range
$0.0002
$0.0002
50-Day Range
$0.00
$0.08
52-Week Range
$0.00
$0.31
Volume
N/A
Average Volume
21,204 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Apotheca Biosciences, Inc. develops cutting-edge medical products, nutraceuticals, formulations, and delivery technologies for the healthcare and consumer care industry in the United States. The company's products include transdermal, sublingual, and nasal delivery devices for dosing of cannabinoids. It also provides CBD pain cream, gel capsules, patches, and sleep tablets; and Promed, anti-aging and cosmetic products. The company was incorporated in 2014 and is based in Saint Petersburg, Florida.

Receive CBDC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apotheca Biosciences and its competitors with MarketBeat's FREE daily newsletter.

CBDC Stock News Headlines

Apotheca Biosciences Inc
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
See More Headlines

CBDC Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Apotheca Biosciences investors own include SoFi Technologies (SOFI), Andersons (ANDE), British American Tobacco (BTI), Copa (CPA), Cronos Group (CRON), FREYR Battery (FREY) and Kraft Heinz (KHC).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:CBDC
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NASDAQ:CBDC) was last updated on 5/11/2025 by MarketBeat.com Staff
From Our Partners